Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment. To aid in achieving this objective, a three-part Expert Panel series published in JACC: CardioOncology, provides a review of the current evidence for the cardiovascular care of patients before, during and after cardiotoxic cancer therapy and highlights gaps in the evidence. In the first installment in the series, an Expert Panel chaired by Zahra Raisi-Estabragh, MBCHB,

Keywords: Cardiology Magazine, ACC Publications, Leadership, Women, Women in Cardiology

As the new year begins, the landscape of cardiovascular medicine is undergoing a remarkable transformation, driven by groundbreaking technologies and innovative approaches that promise to revolutionize patient care. From prevention to detection to diagnosis to treatment, these emerging trends are poised to reshape our understanding and management of cardiovascular diseases. Undoubtedly, the most talked-about trend in cardiovascular medicine today is the latest generation of anti-obesity medications. The

Welcome to the new year stretching out ahead of us like a blank canvas waiting to be painted, created with fresh new ideas and opportunities. In this month’s cover story, we look at five trends that are poised to transform cardiovascular medicine in the year ahead, from prevention to detection to diagnosis to treatment. We also look back at transformative advances in cardiovascular medicine, some of which provide a foundation for those emerging trends, in a feature on a hypothetical Nobel award for the